Schulkers Escalante, Keriann
Bai-Tong, Shiyu S.
Allard, Sarah M.
Ecklu-Mensah, Gertrude
Sanchez, Concepcion
Song, Se Jin
Gilbert, Jack
Bode, Lars
Dorrestein, Pieter
Knight, Rob
Gonzalez, David J.
Leibel, Sydney A.
Leibel, Sandra L.
Article History
Received: 25 March 2024
Revised: 23 June 2024
Accepted: 10 July 2024
First Online: 13 August 2024
Competing interests
: The following authors have no competing interests: K.S.E., S.S.B.T., S.M.A., G.E.M., C.S., S.J.S., J.G., L.B., D.J.G., S.A.L., and S.L.L. R.K. is a scientific advisory board member, and consultant for BiomeSense, Inc., has equity and receives income. He is a scientific advisory board member and has equity in GenCirq. He is a consultant and scientific advisory board member for DayTwo, and receives income. He has equity in and acts as a consultant for Cybele. He is a co-founder of Biota, Inc., and has equity. He is a cofounder of Micronoma, and has equity and is a scientific advisory board member. Pieter Dorrestein is an advisor and holds equity in Cybele and Sirenas and a Scientific co-founder, advisor and holds equity to Ometa, Enveda, and Arome with prior approval by UC San Diego. Pieter Dorrestein also consulted for DSM animal health in 2023. The terms of these arrangements have been reviewed and approved by the University of California, San Diego in accordance with its conflict of interest policies.
: The local ethics committee (#181711) approved the study and written informed consent was obtained from parents before enrollment.